BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35463990)

  • 21. [Semiquantitative parameters of
    Liao XH; Wang RF; Liu M; Chen XQ; Xiong Y; Nong L; Yin L; Zhang BY; DU YJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 53(2):246-254. PubMed ID: 33879893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The significant value of predicting prognosis in patients with colorectal cancer using
    Xu J; Li Y; Hu S; Lu L; Gao Z; Yuan H
    Ann Nucl Med; 2019 Jan; 33(1):32-38. PubMed ID: 30218280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is 18F-fluorodeoxyglucose PET recommended for small lung nodules? CT findings of 18F-fluorodeoxyglucose non-avid lung cancer.
    Sugawara H; Kikkawa N; Ito K; Watanabe H; Kaku S; Akai H; Abe O; Watanabe SI; Yatabe Y; Kusumoto M
    Br J Radiol; 2024 Feb; 97(1154):462-468. PubMed ID: 38308036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A model of malignant risk prediction for solitary pulmonary nodules on
    Yu M; Wang Z; Yang G; Cheng Y
    Thorac Cancer; 2020 May; 11(5):1211-1215. PubMed ID: 32162769
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Li Y; Wu X; Huang Y; Bian D; Jiang L
    Ann Nucl Med; 2020 May; 34(5):314-321. PubMed ID: 32088884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of small pulmonary nodules with little or no 18F-FDG uptake on PET/CT images of patients with nonthoracic malignancies.
    O JH; Yoo IeR; Kim SH; Sohn HS; Chung SK
    J Nucl Med; 2007 Jan; 48(1):15-21. PubMed ID: 17204694
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Qin C; Shao F; Hu F; Song W; Song Y; Guo J; Lan X
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1083-1093. PubMed ID: 31807883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic tumor volume derived from
    Ding C; Mao X; Li N; Huang M; Huang Z; Bao W; Li H; Fan J
    Hell J Nucl Med; 2022; 25(1):63-70. PubMed ID: 35503557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation of primary lung cancer from solitary lung metastasis in patients with colorectal cancer: a retrospective cohort study.
    Lee JE; Jeong WG; Kim YH
    World J Surg Oncol; 2021 Jan; 19(1):28. PubMed ID: 33487164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer.
    Nakanishi K; Nakamura S; Sugiyama T; Kadomatsu Y; Ueno H; Goto M; Ozeki N; Fukui T; Iwano S; Chen-Yoshikawa TF
    BMC Cancer; 2021 Sep; 21(1):983. PubMed ID: 34474680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary tumor standardized uptake value (SUVmax) measured on
    Hui Z; Wei F; Ren H; Xu W; Ren X
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2595-2605. PubMed ID: 32494919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between KRAS mutation and
    Cho A; Jo K; Hwang SH; Lee N; Jung M; Yun M; Hwang HS
    Abdom Radiol (NY); 2017 Jun; 42(6):1621-1626. PubMed ID: 28161825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of prognostic values of primary tumor and nodal
    Lim CH; Hyun SH; Moon SH; Cho YS; Choi JY; Lee KH
    Eur Radiol; 2019 Oct; 29(10):5288-5297. PubMed ID: 30899978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules.
    Lee ST; Berlangieri SU; Poon AM; Mitchell P; Pathmaraj K; Tabone K; Byrne AJ; O'Keefe GJ; Knight SR; Clarke CP; Scott AM
    Intern Med J; 2007 Nov; 37(11):753-9. PubMed ID: 17517082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Large cell neuroendocrine carcinoma of the lung: CT and FDG PET findings.
    Lee KW; Lee Y; Oh SW; Jin KN; Goo JM
    Eur J Radiol; 2015 Nov; 84(11):2332-8. PubMed ID: 26279139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer.
    Liao S; Penney BC; Wroblewski K; Zhang H; Simon CA; Kampalath R; Shih MC; Shimada N; Chen S; Salgia R; Appelbaum DE; Suzuki K; Chen CT; Pu Y
    Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):27-38. PubMed ID: 21946983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Limited diagnostic value of Dual-Time-Point (18)F-FDG PET/CT imaging for classifying solitary pulmonary nodules in granuloma-endemic regions both at visual and quantitative analyses.
    Chen S; Li X; Chen M; Yin Y; Li N; Li Y
    Eur J Radiol; 2016 Oct; 85(10):1744-1749. PubMed ID: 27666611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The preoperative SUVmax for (18)F-FDG uptake predicts survival in patients with colorectal cancer.
    Shi D; Cai G; Peng J; Li D; Li X; Xu Y; Cai S
    BMC Cancer; 2015 Dec; 15():991. PubMed ID: 26689966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Value of Intratumor Metabolic Heterogeneity Parameters on
    Liu X; Xiang K; Geng GY; Wang SC; Ni M; Zhang YF; Pan HF; Lv WF
    Contrast Media Mol Imaging; 2022; 2022():2586245. PubMed ID: 35173559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.